Nerve growth factor signaling in prostate health and disease

3,3'-Diindolylmethane Induction of p75NTR-Dependent Cell Death via the p38 Mitogen-Activated Protein Kinase Pathway in Prostate Cancer Cells

(2009) F. S. Khwaja et al.   Cancer Prevention Research

Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer

(2009) D. Sarker et al.   CLINICAL CANCER RESEARCH

Pathologic basis of focal therapy for early-stage prostate cancer

(2009) Vladimir Mouraviev et al.   Nature Reviews Urology

Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas

(2009) Marisa Clementi et al.   PROSTATE

Targeting Nerve Growth Factor in Pain

(2008) Judy J Watson et al.   BIODRUGS

Multi-targeted therapy of cancer by genistein

(2008) Sanjeev Banerjee et al.   CANCER LETTERS

Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment

(2008) S. Sigala et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Carprofen induction of p75NTR-dependent apoptosis via the p38 mitogen-activated protein kinase pathway in prostate cancer cells

(2008) F. S. Khwaja et al.   MOLECULAR CANCER THERAPEUTICS

Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors

(2008) Yasmina Noubia Abdiche et al.   PROTEIN SCIENCE

EAU Guidelines on Prostate Cancer

(2007) Axel Heidenreich et al.   EUROPEAN UROLOGY

Nerve growth factor as an angiogenic factor

(2007) Beatrice Nico et al.   MICROVASCULAR RESEARCH

The nerve growth factor and its receptors in airway inflammatory diseases

(2007) V. Freund-Michel et al.   PHARMACOLOGY & THERAPEUTICS